Safety study of EG-101 in healthy women
Part of Women’s health & pregnancy clinical trials.
This study tests an experimental drug (EG-101) in healthy women to make sure it is safe before studying it in pregnant women with severe pre-eclampsia. If you join, you will help find a safe dose for treating this dangerous pregnancy condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 55 years old.
- You are generally healthy (no major medical conditions).
- You are not pregnant, not breastfeeding, and use effective birth control (or are past menopause or surgically sterile).
- Your body mass index (BMI) is between 18.5 and 32.
- You are not allergic to the drug Zanamivir.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies ways to lower the risk of pre-eclampsia (dangerous high blood pressure in pregnancy) in women who are having a first pregnancy through IVF/ICSI or who have PCOS. It’s aimed at people considered higher risk for pre-eclampsia.
This trial follows women who have had preeclampsia to learn more about their health after pregnancy. It collects blood and tissue samples to find markers that could improve future care.
This study tests whether taking a daily low-dose aspirin can help prevent pregnancy loss and preeclampsia. It's for women who are in early pregnancy and have certain health risks.
This study looks at how the lining of the womb (the luteal phase) affects the placenta in early pregnancy. It aims to understand why some pregnancies have complications and may help improve care for future pregnancies.
This study is for pregnant women to check their risk of pre-eclampsia (a serious condition causing high blood pressure) using simple tests like blood work or ultrasound. It aims to help you and your doctor manage your pregnancy better.
This study collects samples from pregnant people with preeclampsia (a serious pregnancy blood-pressure condition) and from healthy pregnancy controls. Researchers will study tiny particles (“exosomes”) to see how they differ and whether these signals could help explain or improve care for preeclampsia.
Hear when a new Pre-Eclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.